Novel targeted drugs approved by the NMPA and FDA in 2019
Crossref DOI link: https://doi.org/10.1038/s41392-020-0164-4
Published Online: 2020-05-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Wenjing
Sun, Qiu
Text and Data Mining valid from 2020-05-08
Version of Record valid from 2020-05-08
Article History
Received: 28 March 2020
Accepted: 17 April 2020
First Online: 8 May 2020
Competing interests
: The authors declare no competing interests.